Enzo Biochem’s Life Sciences Unit Reaches $35 Million Patent Infringement Settlement in Delaware With Life Technologies Corporation
Exosome Diagnostics Appoints John Healy as Vice President of Informatics
RNAi Market Worth USD 18.6 Billion by 2030 - 11 RNAi Therapies to be Commercially Available Over Coming Decade - Research and Markets
Global Thoracic Surgery Market Growth of 10.16% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Boston Scientific, Medtronic, Sorin - Research and Markets
Global Biochip Market Worth USD 18.4 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: 3Qbd, Abaxis Inc, Emulate Inc - Research and Markets
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Continued technology advancements and market expansion support Illumina's narrow moat.
Top managers continue to exercise a lot of patience as they look for buying opportunities in a U.S. equity market that has risen close to 40% since the start of 2013.
Get our sector-by-sector take on the bond market, plus our five best bond ideas.
While a majority of our top fund managers are outperforming this year, three of them truly stand out from the rest given their ability to outperform the market over all time periods.